Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV001067585 | SCV001232653 | uncertain significance | Hereditary nonpolyposis colorectal neoplasms | 2019-01-01 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Ala128 amino acid residue in MLH1. Other variant(s) that disrupt this residue have been observed in individuals with MLH1-related conditions (PMID: 9218993, 24362816), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with MLH1-related conditions. This sequence change replaces alanine with serine at codon 128 of the MLH1 protein (p.Ala128Ser). The alanine residue is highly conserved and there is a moderate physicochemical difference between alanine and serine. |